识别前列腺特异性抗原筛查升高后及时随访的障碍:大型医疗系统的回顾性分析
本研究回顾性分析2018至2021年大型医疗系统内28346例前列腺特异性抗原(PSA)升高患者,评估6个月内泌尿外科就诊、前列腺活检或前列腺磁共振成像的及时随访情况。结果显示50.30%及时随访、15.02%未及时随访、34.69%无随访;学术医疗中心患者及时随访的比值比高于社区站点(OR=1.39,95%CI 1.30-1.48)。作者认为需改善各机构间随访一致性与及时性。
要点
- 28346例PSA升高患者中,50.30%在6个月内获得及时随访,34.69%无随访。
- 学术医疗中心患者及时随访可能性高于社区站点(OR=1.39,95%CI 1.30-1.48)。
- 敏感性分析中主站点及时随访比值比更高(OR=1.61,95%CI 1.51-1.73)。
核心结论
- 研究观察到学术医疗中心与社区站点之间随访率存在差异,作者认为需努力改善所有机构前列腺癌随访的一致性和及时性。
研究设计与样本
- 回顾性分析,查询Mass General Brigham企业数据仓库2018至2021年数据,纳入28346例PSA升高并有随访时间记录的患者。
- 及时随访定义为从诊断起6个月内完成泌尿外科预约、前列腺活检或前列腺磁共振成像。
- 按PSA升高诊断地点分层为学术医疗中心与社区站点,并进行单变量和多变量分析。
主要发现
- 28346例患者中,及时随访占50.30%,未及时随访占15.02%,无随访占34.69%。
- 多变量分析中,学术医疗中心就诊患者更可能获得随访(OR=1.39,95%CI 1.30-1.48)。
- 敏感性分析将2家最大社区医院纳入学术医疗设施后,主站点随访患者及时随访的比值比更高(OR=1.61,95%CI 1.51-1.73)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine elevated PSA follow-up within our system and identify areas for improvement in the timely diagnosis of prostate cancer. METHODS: We queried the Mass General Brigham's Enterprise Data Warehouse from 2018-2021, identifying patients with elevated PSA and documented time to follow-up. Timely follow-up was defined as having a urologist appointment, prostate biopsy, or prostate magnetic resonance imaging within 6 months from diagnosis. We stratified the location of elevated PSA diagnosis to academic medical centers versus community sites. Univariable and multivariable analyses were performed to identify factors impacting follow-up. RESULTS: We included 28,346 patients, with 50.30%, 15.02%, and 34.69% receiving timely, untimely, and no follow-up during the study period, respectively. In multivariable analysis, patients seen at academic medical centers were more likely to receive follow-up care (OR=1.39, 95%CI 1.30-1.48). In a sensitivity analysis including 2 of our largest community hospitals as part of academic medical facilities, those following up at our main sites showed even higher odds of timely follow-up (OR=1.61, 95%CI 1.51-1.73). CONCLUSION: Our study observed variations in follow-up rate between our academic medical centers and community sites. This finding highlights the need for efforts to improve consistency and timeliness of prostate cancer follow-up care across all facilities. By addressing interfacility disparities, we can facilitate the delivery of timely care to all patients.
引用
- Qian Z, Chen YJ, Moman P, et al. Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System. Urology. 2024. PMID: 39208942. doi:10.1016/j.urology.2024.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。